Protein Binding of Lopinavir and Ritonavir During 4 Phases of Pregnancy: Implications for Treatment Guidelines
Heather A. Prince(University of North Carolina at Chapel Hill), Angela D. M. Kashuba(University of North Carolina at Chapel Hill), Stephanie A. Malone(Griffith University), Michael G. Hudgens(University of North Carolina at Chapel Hill), Ruili Wang(University of North Carolina at Chapel Hill), Amanda J. Jenkins(University of North Carolina at Chapel Hill), Kimberly K. Scarsi(University of Nebraska Medical Center), Kristine B. Patterson(University of North Carolina at Chapel Hill), Julie B. Dumond(University of North Carolina at Chapel Hill)
Cited by 3
Related Papers
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
|Nature|2012|1.2k
Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission
|Science Translational Medicine|2011|352
A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine
|The Journal of Infectious Diseases|2016|303